US OptionsDetailed Quotes
RDNT250516C45000
- 8.20
- -0.80-8.89%
15min DelayClose May 6 15:59 ET
8.40High8.20Low
8.40Open9.00Pre Close4 Volume27 Open Interest45.00Strike Price3.34KTurnover109.28%IV-0.19%PremiumMay 16, 2025Expiry Date8.30Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8509Delta0.0243Gamma5.83Leverage Ratio-0.1174Theta0.0097Rho4.96Eff Leverage0.0203Vega
RadNet Stock Discussion
Sign in to post a comment
$RadNet (RDNT.US)$
Major AI Breakthrough: RadNet's $103M iCAD Acquisition Transforms Breast Cancer Detection
Major AI Breakthrough: RadNet's $103M iCAD Acquisition Transforms Breast Cancer Detection
1
$RadNet (RDNT.US)$
Could This AI Technology Detect Breast Cancer You Might Otherwise Miss? RadNet's New Partnership Claims 21% Improvement
Could This AI Technology Detect Breast Cancer You Might Otherwise Miss? RadNet's New Partnership Claims 21% Improvement
$RadNet (RDNT.US)$
Can AI Actually Detect Cancer Better Than Doctors? DeepHealth's New Tech Shows Promising Results
Can AI Actually Detect Cancer Better Than Doctors? DeepHealth's New Tech Shows Promising Results
$RadNet (RDNT.US)$
How This RadNet-ConcertAI Partnership Could Transform Radiology Workflow Efficiency
How This RadNet-ConcertAI Partnership Could Transform Radiology Workflow Efficiency
The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
117
14
285
Banks: $JPMorgan (JPM.US)$ $Wells Fargo & Co (WFC.US)$ $Bank of America (BAC.US)$
Capital Markets: $UP Fintech (TIGR.US)$ $Cipher Mining (CIFR.US)$ $CleanSpark (CLSK.US)$
Biotechnology: $Genfit (GNFT.US)$ $Spyre Therapeutics (SYRE.US)$ $Krystal Biotech (KRYS.US)$
Software: $Verb Technology (VERB.US)$ $SurgePays (SURG.US)$ $Uber Technologies (UBER.US)$
Asset Management: $Westwood Holdings (WHG.US)$ $BrightSphere Investment (BSIG.US)$ $Blackrock (BLK.US)$
Specialty Industrial Machinery: $JE Cleantech Holdings Limited (JCSE.US)$ $Taylor Devices (TAYD.US)$ $CSW Industrials (CSWI.US)$
...
Capital Markets: $UP Fintech (TIGR.US)$ $Cipher Mining (CIFR.US)$ $CleanSpark (CLSK.US)$
Biotechnology: $Genfit (GNFT.US)$ $Spyre Therapeutics (SYRE.US)$ $Krystal Biotech (KRYS.US)$
Software: $Verb Technology (VERB.US)$ $SurgePays (SURG.US)$ $Uber Technologies (UBER.US)$
Asset Management: $Westwood Holdings (WHG.US)$ $BrightSphere Investment (BSIG.US)$ $Blackrock (BLK.US)$
Specialty Industrial Machinery: $JE Cleantech Holdings Limited (JCSE.US)$ $Taylor Devices (TAYD.US)$ $CSW Industrials (CSWI.US)$
...
4
1
$RadNet (RDNT.US)$ Significant insider selling in June. Cant blame them.
The combination of a rather low ROE and significant use of debt is not particularly appealing. Investors should consider how a company might perform if it was unable to borrow so easily, as credit markets do change over time.
2
RadNet's high P/S ratio may be due to expectations of accelerated revenue performance. However, with revenue growth forecasted to align with the industry, the elevated P/S ratio may not be sustainable. Maintaining the current share price could be challenging unless RadNet outperforms the industry in the short term.
RadNet's CEO sees the Houston acquisition as a strong platform for growth, with potential for more acquisitions, de novo build-outs, health system partnerships, and expansion of AI and digital health solutions. The Houston market aligns with other successful RadNet core geographies.
1
No comment yet
G3636G : $iCAD Inc (ICAD.US)$ "With over 1,500 healthcare provider locations, facilitating over 8 million annual mammograms in 50 countries, iCAD's installed base and strong sales, engineering and marketing capabilities will provide us with immediate broad and valuable customer relationships and commercialization capabilities that can accelerate our existing DeepHealth objectives," said Dr. Howard Berger, President and CEO of RadNet. "This business combination is expected to accelerate our global leadership and commitment to AI-powered breast cancer screening, and positions us to further advance population health."
The deal will add iCAD's global network of over 1,500 healthcare locations to RadNet's DeepHealth platform, expanding access to advanced screening technologies. The companies believe the combination will speed up innovation, improve early cancer detection, and enhance patient outcomes worldwide